5th generation vs 4th generation troponin T in predicting major adverse cardiovascular events and all-cause mortality in patients hospitalized for non-cardiac indications: A cohort study.
Vedant A GuptaMarc ParanzinoTalal AlnabelsiKaram AyoubJoshua EasonAndin MullisJohn R KotterAndrew ParksLevi MaySethabhisha NerusuChen DaiDaniel ClelandSteve Wah LeungVincent Leigh SorrellPublished in: PloS one (2021)
In patients admitted for a non-cardiac condition, 5th generation TnT is more sensitive although less specific in predicting MACE and ACM. 5th generation TnT identifies an intermediate risk group for ACM previously missed with the 4th generation assay.